2018
DOI: 10.1016/j.biopha.2018.01.120
|View full text |Cite
|
Sign up to set email alerts
|

TGF-β regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
23
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 39 publications
2
23
0
Order By: Relevance
“…Xiao et al found that miR‐124 was significantly decreased in nasopharyngeal carcinoma (NPC) and that a miR‐124 mimic could inhibit NPC cell (CNE1 and CNE2) proliferation, migration, and invasion via binding with the target gene forkhead box Q1 (Foxq1) . In a recent study, miR‐124 inhibited TGF‐β‐induced cell proliferation and migration through SMAD and ERK‐related signaling pathways in NPC cells . Other research on cholangiocarcinoma (CCA) showed that miR‐124 could inhibit cell invasion and metastasis by targeting GATA6 .…”
Section: Mir‐124 and Other Malignant Tumorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Xiao et al found that miR‐124 was significantly decreased in nasopharyngeal carcinoma (NPC) and that a miR‐124 mimic could inhibit NPC cell (CNE1 and CNE2) proliferation, migration, and invasion via binding with the target gene forkhead box Q1 (Foxq1) . In a recent study, miR‐124 inhibited TGF‐β‐induced cell proliferation and migration through SMAD and ERK‐related signaling pathways in NPC cells . Other research on cholangiocarcinoma (CCA) showed that miR‐124 could inhibit cell invasion and metastasis by targeting GATA6 .…”
Section: Mir‐124 and Other Malignant Tumorsmentioning
confidence: 99%
“…107 In a recent study, miR-124 inhibited TGF-β-induced cell proliferation and migration through SMAD and ERK-related signaling pathways in NPC cells. 108 Other research on cholangiocarcinoma (CCA) showed that miR-124 could inhibit cell invasion and metastasis by targeting GATA6. 109 In regard to gallbladder carcinoma, studies showed that miR-124 had a decreased expression level in clinical samples and cell lines (QBC939 and GBC-SD).…”
Section: Malignant Tumorsmentioning
confidence: 99%
“…Fan Y and colleagues showed that upregulation of MALAT1 promotes bladder cancer metastasis induced by TGF-β 31 . Wang Y et al 32 evaluated expression variation of MALAT1 after treated with TGF-β, finding that TGF-β significantly induced malat1 levels in human head and neck squamous cell carcinoma cells; subsequent similar work by Du MY et al 33 detected MALAT1 expression variation in 6-10B cells treated with TGF-β by way of qRT-PCR, showing that TGF-β treatment increased MALAT1 expression in nasopharyngeal carcinoma. The two independent studies fundamentally established the relationship between TGF-β1 and MALAT1 in outline; although the detailed regulation remains to be fleshed out with more data and evidence.…”
Section: Discussionmentioning
confidence: 95%
“…Researchers found that SMAD4 plays a tumor suppressor role in many cancers, such as gastric cancer (GC), colorectal cancer, and cholangiocarcinoma . However, a large number of research showed that SMAD4, a significant factor in the TGF‐β/SMAD4 signaling pathway, plays a crucial part in signaling into the cell membrane and can contribute to the progression of EMT, Unfortunately, The specific role of SMAD4 in TGF‐β‐induced EMT in ESCC remains understudied. We provided evidence that knocking down of SMAD4 expression could partially reverse TGF‐induced EMT progression, increases E‐Cadherin protein expression, decreases N‐Cadherin and vimentin protein expression, and inhibits the invasion and migration of EC‐1 cells.…”
Section: Discussionmentioning
confidence: 99%